Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Neuroimaging Clinics of North America|December 7, 2006
Applications of clinical dopamine imagingKimberly P Lindsey, S John GatleyThe Journal of Pharmacology and Experimental Therapeutics|November 10, 2005
Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brainSherrye T Glaser, S John Gatley, Andrew N GiffordCurrent Psychiatry Reports|September 19, 2003
Neuroimaging in drug abuseKimberly P Lindsey, S John Gatley, Nora D VolkowDrug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2008
Biodistribution of radiolabeled ethanol in rodentsAndrew N Gifford, Mel Pilar Espaillat, S John GatleyJournal of Labelled Compounds & Radiopharmaceuticals|March 23, 2011
The preparation of 2-O-[1'-C]arachidonoyl-1-O-stearoyl-sn-glycerolRichard I Duclos, S John Gatley, Shachi R Bhatt, et al.Chemistry and Physics of Lipids|December 31, 2002
In vivo imaging of the brain cannabinoid receptorAndrew N Gifford, Alexandros Makriyannis, Nora D Volkow, et al.Neuroscience|July 14, 2015
Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in ratsT S Bender, M M Migliore, R B Campbell, et al.Nuclear Medicine and Biology|May 10, 2005
Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compoundsZizhong Li, Andrew Gifford, Qian Liu, et al.The Journal of Organic Chemistry|March 5, 2011
A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG)Richard I Duclos, Meghan Johnston, Subramanian K Vadivel, et al.Pageof 3